TRVN RSI Chart
Last 30 days
5%
Last 90 days
-26.3%
Trailing 12 Months
-62.0%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 0 | 0 | 0 | 0 |
2023 | 2.0M | 2.4M | 2.8M | 3.1M |
2022 | 932.4K | 1.3M | 0 | 1.7M |
2021 | 3.3M | 3.5M | 637.0K | 567.0K |
2020 | 4.7M | 4.1M | 3.6M | 3.1M |
2019 | 0 | 0 | 0 | 5.2M |
2018 | 0 | 4.4M | 5.5M | 5.7M |
2016 | 7.5M | 7.5M | 5.6M | 3.8M |
2015 | 1.6M | 3.0M | 4.4M | 6.3M |
2013 | 339.4K | 271.3K | 203.1K | 135.0K |
2012 | 0 | 0 | 0 | 407.6K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Dec 14, 2023 | drake patricia m. | sold (taxes) | -1,119 | 0.61 | -1,835 | svp, chief commercial officer |
Dec 14, 2023 | demitrack mark | acquired | 143,350 | 0.61 | 235,000 | svp, chief medical officer |
Dec 14, 2023 | shin barry | sold (taxes) | -2,205 | 0.61 | -3,616 | svp, cfo |
Dec 14, 2023 | yoder robert t | sold (taxes) | -1,176 | 0.61 | -1,929 | svp, chief business officer |
Dec 14, 2023 | bourdow carrie l. | acquired | 286,700 | 0.61 | 470,000 | president & ceo |
Dec 14, 2023 | yoder robert t | acquired | 71,675 | 0.61 | 117,500 | svp, chief business officer |
Dec 14, 2023 | shin barry | acquired | 143,350 | 0.61 | 235,000 | svp, cfo |
Dec 14, 2023 | bourdow carrie l. | sold (taxes) | -4,345 | 0.61 | -7,123 | president & ceo |
Dec 14, 2023 | demitrack mark | sold (taxes) | -2,191 | 0.61 | -3,593 | svp, chief medical officer |
Dec 14, 2023 | drake patricia m. | acquired | 45,750 | 0.61 | 75,000 | svp, chief commercial officer |
Which funds bought or sold TRVN recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 15, 2024 | STATE STREET CORP | unchanged | - | -6,107 | 11,437 | -% |
May 15, 2024 | CITADEL ADVISORS LLC | added | 72.04 | 5,797 | 53,471 | -% |
May 15, 2024 | Royal Bank of Canada | reduced | -43.66 | - | - | -% |
May 15, 2024 | MILLENNIUM MANAGEMENT LLC | sold off | -100 | -7,210 | - | -% |
May 15, 2024 | CAPTRUST FINANCIAL ADVISORS | sold off | -100 | -23,829 | - | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | added | 3.24 | -1,647 | 3,165 | -% |
May 15, 2024 | ARMISTICE CAPITAL, LLC | added | 93.25 | 133,116 | 709,145 | 0.01% |
May 15, 2024 | Steward Partners Investment Advisory, LLC | sold off | -100 | -29.00 | - | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | added | 20.9 | -107 | 356 | -% |
May 15, 2024 | MORGAN STANLEY | unchanged | - | -2,687 | 4,714 | -% |
Unveiling Trevena Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Trevena Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Trevena Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2018Q4 | 2018Q3 | 2018Q2 | 2016Q4 |
Revenue | - | - | - | 180,000 | 3,021,000 | 2,014,000 | 1,007,000 | - | 20,000 | 100,500 | 181,000 | 178,000 | 209,000 | 69,000 | 3,000,000 | 2,308,000 | 1,616,000 | 924,000 | 232,000 | 3,000,000 | 2,500,000 | - |
Cost Of Revenue | -93.1% | 88,000 | 1,280,500 | 175,000 | 88,000 | 127,000 | 227,000 | 216,000 | 207,000 | 334,000 | 199,000 | 258,000 | 163,000 | - | - | - | - | - | - | - | - | - |
Costs and Expenses | -1.7% | 9,898,000 | 10,064,500 | 9,007,000 | 9,217,000 | 10,125,000 | 9,347,000 | 14,813,000 | 16,480,000 | 14,032,000 | 14,041,000 | 14,252,000 | 10,167,000 | 12,083,000 | 8,390,000 | 6,258,000 | 5,823,000 | - | - | - | - | - |
Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 8,390,000 | 6,258,000 | 5,823,000 | 6,501,000 | 8,184,000 | 7,258,000 | 11,095,000 | 35,835,000 |
S&GA Expenses | -100.0% | - | 4,611,000 | 4,572,000 | 5,138,000 | 6,089,000 | 5,725,000 | 10,306,000 | 11,014,000 | 9,761,000 | 10,438,000 | 10,545,000 | 7,368,000 | 8,227,000 | 4,089,000 | 3,300,000 | 3,632,000 | 3,640,000 | 4,073,000 | 3,908,000 | 5,926,000 | - |
R&D Expenses | -5.0% | 3,965,000 | 4,173,000 | 4,260,000 | 3,991,000 | 3,909,000 | 3,395,000 | 4,291,000 | 5,259,000 | 3,937,000 | 3,404,000 | 3,449,000 | 2,636,000 | 3,674,000 | 4,301,000 | 2,958,000 | 2,191,000 | 2,861,000 | 2,748,000 | 3,350,000 | 5,128,000 | - |
EBITDA Margin | 0.2% | -13.07 | -13.09 | -15.29 | -17.54 | -21.08 | -25.97 | -34.23 | -47.64 | -78.34 | -57.51 | -8.27 | -8.75 | - | - | - | - | - | - | - | - | - |
Interest Expenses | -72.5% | 513,000 | 1,866,000 | 210,000 | 1,122,000 | 446,000 | 530,000 | 325,000 | - | - | - | - | - | - | - | - | 29,000 | 117,000 | 441,000 | 515,000 | 597,000 | - |
Earnings Before Taxes | - | - | - | - | - | - | - | - | - | -13,953,000 | -13,771,000 | - | - | -11,871,000 | -5,251,000 | -6,222,000 | -5,725,000 | -6,445,000 | -7,976,000 | -4,483,000 | -8,559,000 | - |
EBT Margin | 0% | -14.35 | -14.35 | -16.25 | -18.73 | -22.11 | -26.96 | -34.55 | -48.10 | -79.09 | -58.27 | -8.41 | -8.91 | - | - | - | - | - | - | - | - | - |
Net Income | 53.4% | -7,700,000 | -16,528,000 | -7,930,000 | -8,012,000 | -7,819,000 | -6,987,500 | -14,981,000 | -16,389,000 | -13,970,500 | -13,771,000 | -14,022,000 | -9,842,000 | -11,871,000 | -5,551,000 | -6,222,000 | -5,725,000 | -6,445,000 | -7,976,000 | -4,483,000 | -9,304,000 | - |
Net Income Margin | 0.3% | -12.85 | -12.89 | -11.14 | -15.92 | -22.22 | -32.26 | -45.55 | -62.37 | -91.01 | -77.72 | -11.95 | -10.26 | - | - | - | - | - | - | - | - | - |
Free Cashflow | -57.2% | -9,441,000 | -6,006,000 | -8,926,000 | -7,250,000 | -10,874,000 | -10,664,000 | -11,950,000 | -18,257,000 | -12,616,000 | -10,913,000 | -11,835,000 | -14,203,000 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -23.3% | 31.00 | 41.00 | 45.00 | 39.00 | 38.00 | 49.00 | 51.00 | 65.00 | 64.00 | 80.00 | 92.00 | 112 | 118 | 128 | 123 | 66.00 | 39.00 | 47.00 | 57.00 | 65.00 | 72.00 |
Current Assets | -26.2% | 26.00 | 35.00 | 39.00 | 33.00 | 31.00 | 41.00 | 43.00 | 56.00 | 54.00 | 71.00 | 82.00 | 103 | 110 | 119 | 114 | 57.00 | 30.00 | 37.00 | 47.00 | 55.00 | 62.00 |
Cash Equivalents | -26.9% | 24.00 | 33.00 | 35.00 | 28.00 | 27.00 | 38.00 | 25.00 | 23.00 | 50.00 | 68.00 | 80.00 | 92.00 | 99.00 | 111 | 114 | 56.00 | 29.00 | 34.00 | 31.00 | 25.00 | 22.00 |
Inventory | - | - | - | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 3.00 | 3.00 | 2.00 | 1.00 | 1.00 | - | - | - | - | - | - | - | - | - |
Net PPE | -7.4% | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
Liabilities | -5.1% | 46.00 | 48.00 | 42.00 | 29.00 | 28.00 | 33.00 | 29.00 | 29.00 | 15.00 | 15.00 | 14.00 | 22.00 | 20.00 | 24.00 | 11.00 | 11.00 | 10.00 | 17.00 | 22.00 | 23.00 | 26.00 |
Current Liabilities | -4.6% | 7.00 | 8.00 | 6.00 | 8.00 | 8.00 | 9.00 | 9.00 | 10.00 | 9.00 | 9.00 | 7.00 | 15.00 | 14.00 | 17.00 | 4.00 | 4.00 | 3.00 | 9.00 | 14.00 | 15.00 | 17.00 |
Long Term Debt | 1.6% | 31.00 | 31.00 | 30.00 | 14.00 | 13.00 | 13.00 | 13.00 | 13.00 | - | - | - | - | - | - | - | - | - | - | - | - | - |
LT Debt, Current | - | - | - | - | - | - | - | 0.00 | - | - | - | - | - | - | - | - | - | - | 5.00 | 8.00 | 11.00 | 14.00 |
LT Debt, Non Current | -100.0% | - | 31.00 | 30.00 | 14.00 | 13.00 | 13.00 | 13.00 | 13.00 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shareholder's Equity | -91.4% | -14.65 | -7.66 | 4.00 | 10.00 | 10.00 | 16.00 | 22.00 | 36.00 | 49.00 | 65.00 | 78.00 | 91.00 | 98.00 | 104 | 111 | 55.00 | 29.00 | 30.00 | 35.00 | 42.00 | 46.00 |
Retained Earnings | -1.3% | -595 | -588 | -571 | -563 | -555 | -547 | -540 | -525 | -510 | -494 | -480 | -466 | -452 | -442 | -430 | -425 | -418 | -413 | -406 | -398 | -393 |
Additional Paid-In Capital | 0.1% | 581 | 580 | 575 | 573 | 566 | 563 | 562 | 561 | 560 | 559 | 558 | 557 | 550 | 546 | 542 | 480 | 448 | 443 | 441 | 440 | 440 |
Shares Outstanding | 6.0% | 18.00 | 17.00 | 15.00 | 14.00 | 9.00 | 8.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 6.00 | 6.00 | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 12.00 | - | - | - | 276 | - | - | - | 276 | - | - | - | 189 | - | - | - | 94.00 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -57.4% | -9,420 | -5,985 | -8,926 | -7,250 | -10,874 | -10,664 | -10,606 | -11,950 | -18,257 | -12,616 | -11,123 | -12,045 | -14,413 | -7,132 | -2,723 | -5,321 | -6,218 | -6,805 | -6,161 | -3,018 | -7,683 |
Share Based Compensation | -7.1% | 681 | 733 | 689 | 702 | 806 | 749 | 764 | 1,008 | 1,155 | 1,136 | 978 | 1,182 | 1,111 | 840 | 787 | 766 | 891 | 917 | 768 | 793 | 754 |
Cashflow From Investing | 100.0% | - | -21.00 | - | - | - | 18,000 | 11,994 | - | - | 1,164 | -390 | -374 | -416 | -27.00 | - | - | 3,500 | 11,998 | 14,768 | 9,857 | -11,040 |
Cashflow From Financing | -100.1% | -3.00 | 4,029 | 15,781 | 6,503 | -2.00 | 7,956 | 1,100 | 14,451 | -2.00 | -271 | -2.00 | 5,277 | 2,730 | 3,880 | 60,610 | 32,026 | -1,496 | -2,142 | -3,176 | -3,273 | 6,094 |
Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Revenue: | ||
Total revenue | $ 20 | $ 6 |
Operating expenses: | ||
Cost of goods sold | 88 | 127 |
Selling, general and administrative | 5,845 | 6,089 |
Research and development | 3,965 | 3,909 |
Total operating expenses | 9,898 | 10,125 |
Loss from operations | (9,878) | (10,119) |
Other income (expense): | ||
Change in fair value of warrant liability | 2,361 | 2,466 |
Other income (expense), net | 4 | 9 |
Interest income | 353 | 289 |
Interest expense | (513) | (446) |
Loss on foreign currency exchange | (5) | (18) |
Total other income, net | 2,200 | 2,300 |
Net loss | (7,678) | (7,819) |
Other comprehensive loss | ||
Unrealized gain on marketable securities | 1 | |
Comprehensive loss | $ (7,678) | $ (7,818) |
Per share information: | ||
Net loss per share of common stock, basic (in dollars per share) | $ (0.36) | $ (0.81) |
Net loss per share of common stock, diluted (in dollars per share) | $ (0.36) | $ (0.81) |
Weighted average common shares outstanding, basic (in shares) | 21,303,390 | 9,594,072 |
Weighted average common shares outstanding, diluted (in shares) | 21,303,390 | 9,594,072 |
Product revenue | ||
Revenue: | ||
Total revenue | $ 20 | $ 6 |
Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 23,552 | $ 32,975 |
Prepaid expenses and other current assets | 2,426 | 2,230 |
Total current assets | 25,978 | 35,205 |
Restricted cash | 540 | 540 |
Property and equipment, net | 1,107 | 1,195 |
Right-of-use lease assets | 3,512 | 3,665 |
Total assets | 31,137 | 40,605 |
Current liabilities: | ||
Accounts payable, net | 2,327 | 2,303 |
Accrued expenses and other current liabilities | 3,839 | 4,239 |
Lease liabilities | 1,041 | 1,012 |
Total current liabilities | 7,207 | 7,554 |
Loans payable, net | 31,317 | 30,809 |
Leases, net of current portion | 4,153 | 4,424 |
Warrant liability | 3,114 | 5,475 |
Total liabilities | 45,791 | 48,262 |
Stockholders' (deficit) equity: | ||
Preferred stock-$0.001 par value; 5,000,000 shares authorized, none issued or outstanding at March 31, 2024 and December 31, 2023 | ||
Common stock-$0.001 par value; 200,000,000 shares authorized at March 31, 2024 and December 31, 2023; 18,321,010 and 17,289,104 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively | 18 | 17 |
Additional paid-in capital | 581,067 | 580,387 |
Accumulated deficit | (595,739) | (588,061) |
Total stockholders' deficit | (14,654) | (7,657) |
Total liabilities and stockholders' deficit | $ 31,137 | $ 40,605 |